Putting blood pressure in its place.
The benefit of blood pressure-lowering therapy in individuals with normal blood pressure who are at high cardiovascular risk creates a challenge in how best to advocate such therapy. Arguments based on a putative causal role for blood pressure and the need to reduce blood pressure may be less likely to succeed than arguments based on the need to prevent and to reverse the cardiovascular disease that causes cardiovascular events.